El-Taji, O., Rush, H., Murphy, L., Sachdeva, A., Brown, L. C., Attard, G., James, N. D., Parmar, M., Gillessen, S., Clarke, N. W. (2026). Adding metformin to androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC): Quality of life (QoL) results from STAMPEDE.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.135